Vanda Pharmaceuticals Inc. (VNDA)
Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.
Address
2200 PENNSYLVANIA AVE NW
WASHINGTON, DC 20037
Founded
2002
Number of Employees
203
Website
http://www.vandapharma.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)